找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

SCIE期刊JOURNAL OF LEUKOCYTE BIOLOGY 2024/2025影响因子:3.609 (J LEUKOCYTE BIOL) (0741-5400). (IMMUNOLOGY)(免疫学)Science Citatio

[复制链接]
楼主: aspirant
发表于 2025-3-25 07:22:44 | 显示全部楼层
Submitted on: 03 February 2021. Revised on: 24 May 2021. Accepted on: 27 June 2021. ___________________JOURNAL OF LEUKOCYTE BIOLOGY---OXFORD UNIV PRESS
发表于 2025-3-25 11:24:02 | 显示全部楼层
Submitted on: 26 March 2014. Revised on: 20 July 2014. Accepted on: 18 August 2014. ___________________JOURNAL OF LEUKOCYTE BIOLOGY---OXFORD UNIV PRESS
发表于 2025-3-25 13:07:31 | 显示全部楼层
发表于 2025-3-25 16:39:39 | 显示全部楼层
Submitted on: 03 February 2017. Revised on: 31 March 2017. Accepted on: 27 April 2017. ___________________JOURNAL OF LEUKOCYTE BIOLOGY---OXFORD UNIV PRESS
发表于 2025-3-25 21:44:23 | 显示全部楼层
Submitted on: 28 October 2000. Revised on: 28 December 2000. Accepted on: 13 January 2001. ___________________JOURNAL OF LEUKOCYTE BIOLOGY---OXFORD UNIV PRESS
发表于 2025-3-26 00:41:20 | 显示全部楼层
Submitted on: 31 May 2006. Revised on: 30 July 2006. Accepted on: 17 September 2006. ___________________JOURNAL OF LEUKOCYTE BIOLOGY---OXFORD UNIV PRESS
发表于 2025-3-26 04:24:11 | 显示全部楼层
Submitted on: 06 March 2009. Revised on: 11 May 2009. Accepted on: 31 May 2009. ___________________JOURNAL OF LEUKOCYTE BIOLOGY---OXFORD UNIV PRESS
发表于 2025-3-26 10:01:04 | 显示全部楼层
Submitted on: 29 December 2017. Revised on: 10 March 2018. Accepted on: 21 March 2018. ___________________JOURNAL OF LEUKOCYTE BIOLOGY---OXFORD UNIV PRESS
发表于 2025-3-26 14:58:50 | 显示全部楼层
发表于 2025-3-26 18:37:49 | 显示全部楼层
Submitted on: 04 April 2018. Revised on: 30 April 2018. Accepted on: 18 May 2018. ___________________JOURNAL OF LEUKOCYTE BIOLOGY---OXFORD UNIV PRESS
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-4 14:38
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表